Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”

Matrix crosslinking decreases cell migration persistence. by Michael Pamonag (12295175)

Decreased Aβ42 halo overlaps with the decreased incidence of DNs in FO treated mice. by Milena Jović (6707702)

“…(E-H) In the FO-treated 5xFAD animals the decreased surface of the Aβ halo overlaps with the decreased incidence of swollen, dystrophic neurites.…”

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

“…Additionally, X-ray micro-computed tomography technique was employed to observe the microstructure and determine the porosity of rock salt samples depending on the temperature. The V_p and the σ_t of Çankırı rock salt decrease with increasing temperatures of samples whereas the σ_c increases. …”

Inhibition of the mitochondrial fission decreases mtROS production. by Dong Ma (584680)

Subjects:

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

“…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”

Decreased expression of V-ATPase upon the siRNA transfection. by Manisha Naskar (2613763)

MMP-2 production is decreased following ALK5 inhibition. by Rebecca A. Scott (488956)

Gut richness and diversity decrease significantly by week 5 of chemoradiotherapy. by Molly B. El Alam (10231830)

Decreased expression of ATG5 upon the siRNA transfection. by Manisha Naskar (2613763)

Modifying pregnenolone to decrease its lipophilicity results in decreased cellular uptake. by Jeffrey M. McManus (7512926)

Decreased transcription of <i>prs</i> results in decreased growth. by Javiera Norambuena (137228)

Subjects:

Fig 5 - by Pierre Bauvin (18154818)

Subjects:

ERK inhibition decreases CDK1 and Smo expression. by Xiaojuan Li (351842)

DDX3 levels are not decreased in MCMV-infected cells. by Olha Puhach (9500132)

Decreased Expression of TGR5 in Vogt-Koyanagi-Harada (VKH) Disease by Jinglu Yang (6391913)

“…</p> <p><i>Results</i>: A decreased expression of TGR5 in M1 macrophages was observed in active VKH patients as compared with normal controls. …”

Pathway associated with decreased inflammation. by Monica N. Mweetwa (17054522)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Subjects: